fingolimod hydrochloride has been researched along with Eperythrozoonosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, Y; Ide, T; Isobe, R; Jinno, R; Kawabe, Y; Muramatsu, E; Ritsuno, Y; Sakurai, A; Sasaki, T; Tsutsumi, Y | 1 |
1 other study(ies) available for fingolimod hydrochloride and Eperythrozoonosis
| Article | Year |
|---|---|
Periprosthetic joint infection due to Mycoplasma hominis in a multiple sclerosis patient treated with fingolimod.
Topics: Anti-Infective Agents; Arthritis, Infectious; Fingolimod Hydrochloride; Humans; Male; Middle Aged; Multiple Sclerosis; Mycoplasma hominis; Mycoplasma Infections; Prosthesis-Related Infections; Sepsis; Sphingosine-1-Phosphate Receptors | 2022 |